Dr. rer. nat. Pawel Zerr

List of publications:

BibTeX-Download


Department of Medicine 3 – Rheumatology and Immunology
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages (2015) Beyer C, Huang J, Beer J, Zhang Y, Palumbo-Zerr K, Zerr P, Distler A, et al. Journal article The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis (2014) Avouac J, Palumbo-Zerr K, Ruzehaji N, Tomcik M, Zerr P, Dees C, Distler A, et al. Journal article The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis (2014) Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, et al. Journal article Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-? signalling to prevent fibrosis (2014) Tomcik M, Zerr P, Pitkowski J, Palumbo-Zerr K, Avouac J, Distler O, Becvar R, et al. Journal article Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis. (2012) Ruiz-Heiland G, Horn A, Zerr P, Hofstetter W, Baum W, Stock M, Distler J, et al. Journal article The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis (2012) Krönke G, Reich N, Scholtysek C, Akhmetshina A, Uderhardt S, Zerr P, Palumbo K, et al. Journal article Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis (2012) Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, et al. Journal article Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis (2012) Avouac J, Palumbo K, Tomcik M, Zerr P, Dees C, Horn A, Maurer B, et al. Journal article
‹ 1 2 ›